⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
XAIR News
Beyond Air, Inc. Common Stock
Peanut Allergy Market Analysis Report 2025-2035: PALFORZIA and Xolair Approvals, Improved Diagnosis and Innovative Drug Delivery Platforms Drive Growth
globenewswire.com
XAIR
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
globenewswire.com
JUNS
DYAI
PHIO
CVKD
TNXP
MTVA
XAIR
AEMD
NSRX
ICU
JAGX
Beyond Air to Participate in the 38th Annual Roth Conference in March
globenewswire.com
XAIR
Beyond Air to Participate in the 38th Annual Roth Conference in March
globenewswire.com
XAIR
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
globenewswire.com
XAIR
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
globenewswire.com
XAIR
Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections
globenewswire.com
XAIR
Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
XAIR
Beyond Cancer Abstract Featuring Phase 1 Data on Intratumoral Ultra-High Concentration Nitric Oxide (UNO) in Solid Tumor Metastases to be Presented at the AACR Annual Meeting 2026
globenewswire.com
XAIR
Diagnostic Specialty Antibodies Research Report 2026 - Global Market Size, Trends, Competitive Analysis, Opportunities, and Forecasts, 2021-2025 & 2026-2031
globenewswire.com
XAIR